Dual block with lapatinib and trastuzumab versus single-agent trastuzumab combined with chemotherapy as neoadjuvant treatment of HER2-positive breast cancer: A meta-analysis of randomized trials
Matteo Clavarezza, Matteo Puntoni, Alessandra Gennari, Laura Paleari, Nicoletta Provinciali, Mauro D'Amico, Andrea DeCensi
Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review
Fingerprint
Entra nei temi di ricerca di 'Dual block with lapatinib and trastuzumab versus single-agent trastuzumab combined with chemotherapy as neoadjuvant treatment of HER2-positive breast cancer: A meta-analysis of randomized trials'. Insieme formano una fingerprint unica.